Rehmann Capital Advisory Group’s Bio-Techne TECH Stock Holding History

Rehmann Capital Advisory Group’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,012	Closed	-$218K	–	556
2022 Q1	$218K	Hold	2,012	–	–	0.02%	484
2021 Q4	$260K	Hold	2,012	–	–	0.02%	468
2021 Q3	$244K	Hold	2,012	–	–	0.02%	480
2021 Q2	$226K	Buy	+2,012	New	+$212K	0.02%	496
2019 Q3	$99.8K	Sell	2,040 -396	-16%	-$19.9K	0.01%	448
2019 Q2	$127K	Hold	2,436	–	–	0.02%	544
2019 Q1	$121K	Buy	2,436 +396	+19%	+$17.8K	0.02%	539
2018 Q4	$73.8K	Hold	2,040	–	–	0.01%	477
2018 Q3	$104K	Sell	2,040 -36	-2%	-$1.59K	0.01%	576
2018 Q2	$76.8K	Sell	2,076 -96	-4%	-$3.67K	0.01%	641
2018 Q1	$82K	Buy	+2,172	New	+$76.7K	0.01%	602

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

DDC

DF Dent & Co Baltimore, Maryland $5.27B AUM 7.89% 1-Year Est. Return

Rehmann Capital Advisory Group's TECH Position: Q2 2022 in Review

Rehmann Capital Advisory Group sold out of Bio-Techne (TECH) in Q2 2022, closing a stake of 2,012 shares — an estimated $218K sold.

Rehmann Capital Advisory Group first reported a position in TECH in Q1 2018 and held it in 11 quarters. The position peaked at $260K in Q4 2021. 550 funds tracked by Wall St. Rank hold TECH as of Q2 2022.

Rehmann Capital Advisory Group reported no remaining Bio-Techne position as of Q2 2022 after selling out during the quarter.
Rehmann Capital Advisory Group sold 2,012 Bio-Techne shares in Q2 2022, an estimated $218K.
Rehmann Capital Advisory Group first reported a position in Bio-Techne in Q1 2018 and held it in 11 quarters.
Rehmann Capital Advisory Group's Bio-Techne position peaked at $260K in Q4 2021.
550 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2022.

Based on Rehmann Capital Advisory Group's 13F filing for Q2 2022, filed 12 Aug 2022.